Cancer Diagnostics
Sheila E. Taube, James W. Jacobson, Tracy Lively · American Journal of PharmacoGenomics · 2005
Cited by 33 works. doi:10.2165/00129785-200505060-00003
Authors
References
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
- Molecular portraits of human breast tumours
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
- A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
- Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
- Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer